Off-label Use for Direct Oral Anticoagulants: Valvular Atrial Fibrillation, Heart Failure, Left Ventricular Thrombus, Superficial Vein Thrombosis, Pulmonary Hypertension-a Systematic Review.
CONCLUSION: DOACs can be considered for AF complicated by VHD except for mitral stenosis or mechanical valve replacement. DOACs (especially rivaroxaban) are considered as an alternative therapy for SVT and CTEPH. Further prospective studies for DOAC uses are needed for HF or LVT.
PMID: 33148014 [PubMed - as supplied by publisher]
Source: The Annals of Pharmacotherapy - Category: Drugs & Pharmacology Authors: Brokmeier H, Kido K Tags: Ann Pharmacother Source Type: research
More News: Alternative and Complementary Therapies | Atrial Fibrillation | Cardiology | Coumadin | Databases & Libraries | Drugs & Pharmacology | Heart | Heart Disease | Heart Failure | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Hypertension | Pulmonary Hypertension | Pulmonary Thromboembolism | Study | Thrombosis | Warfarin